
Update on the HTA Coordination Group subgroup meetings held on April 25 and 26.
Their collective efforts will surely shape the HTA landscape in the long run.
Recent Posts
Transforming Healthcare with the Gene Therapy Access Model
The gene therapy access model is a groundbreaking federal-state collaborative framework designed to improve how transformative treatments are distributed and financed, particularly within Medicaid. This innovative approach answers a key question for patients and policymakers: How can we ensur...
PhRMA’s Patient Access Investment: $500 Billion Commitment to Domestic Infrastructure and Care
Yesterday PhRMA announced steps to boosting patient access to treatments. The announcement showcases the U.S. biopharmaceutical industry’s initiative to enhance patient access and stimulate economic growth. The announcement outlines a remarkable $500 billion in new U.S. infrastructure spending. I...
Empowering Innovation: Clinical Trials Reform Strategies by EMA for 2025
The recently published European Medicines Agency (EMA) article addresses the strategic targets for improving the clinical trials reform landscape in Europe. It emphasizes measures that foster innovation, collaboration, and efficiency in clinical research. The article outlines new priorities for 2...